Zhang M, Jiang L, Liu X, Liu F, Zhang H, Zhang Y
Heliyon. 2024; 10(1):e24287.
PMID: 38234923
PMC: 10792648.
DOI: 10.1016/j.heliyon.2024.e24287.
Szczepanek J, Skorupa M, Jarkiewicz-Tretyn J, Cybulski C, Tretyn A
Int J Mol Sci. 2023; 24(8).
PMID: 37108398
PMC: 10138995.
DOI: 10.3390/ijms24087235.
Xu J, Xu J, Liu X, Jiang J
Cell Death Discov. 2022; 8(1):287.
PMID: 35697671
PMC: 9192730.
DOI: 10.1038/s41420-022-01061-x.
Wu X, Kong C, Wu Y
Bioengineered. 2021; 12(1):9046-9057.
PMID: 34657558
PMC: 8806954.
DOI: 10.1080/21655979.2021.1993715.
Volovat S, Volovat C, Hordila I, Hordila D, Mirestean C, Miron O
Front Oncol. 2020; 10:526850.
PMID: 33330019
PMC: 7716774.
DOI: 10.3389/fonc.2020.526850.
[Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia].
Hanafi A, Jayusman A, Alfasunu S, Sadewa A, Pramono D, Heriyanto D
Zhongguo Fei Ai Za Zhi. 2020; 23(5):321-332.
PMID: 32283582
PMC: 7260391.
DOI: 10.3779/j.issn.1009-3419.2020.104.02.
Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.
Bhat A, Younes S, Raza S, Zarif L, Nisar S, Ahmed I
Mol Cancer. 2020; 19(1):57.
PMID: 32164715
PMC: 7069174.
DOI: 10.1186/s12943-020-01175-9.
Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.
Konstantinidis A, Pardali D, Adamama-Moraitou K, Gazouli M, Dovas C, Legaki E
BMC Vet Res. 2020; 16(1):69.
PMID: 32087719
PMC: 7035774.
DOI: 10.1186/s12917-020-02287-6.
Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.
Fadaka A, Pretorius A, Klein A
Int J Mol Sci. 2019; 20(20).
PMID: 31635135
PMC: 6834124.
DOI: 10.3390/ijms20205190.
Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome.
Liu S, Feng S, Luo D
Int Urogynecol J. 2018; 30(9):1487-1495.
PMID: 30456462
DOI: 10.1007/s00192-018-3817-x.
Pre-microRNA Gene Polymorphisms and Risk of Cervical Squamous Cell Carcinoma.
Srivastava S, Singh S, Fatima N, Mittal B, Srivastava A
J Clin Diagn Res. 2017; 11(9):GC01-GC04.
PMID: 29207732
PMC: 5713754.
DOI: 10.7860/JCDR/2017/25361.10543.
Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
Oduor C, Kaymaz Y, Chelimo K, Otieno J, Ongecha J, Moormann A
BMC Cancer. 2017; 17(1):761.
PMID: 29132323
PMC: 5683570.
DOI: 10.1186/s12885-017-3711-9.
miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
Pekow J, Meckel K, Dougherty U, Huang Y, Chen X, Almoghrabi A
Clin Cancer Res. 2017; 23(17):5281-5291.
PMID: 28600480
PMC: 5581687.
DOI: 10.1158/1078-0432.CCR-17-0171.
MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A.
Wang L, Yao J, Sun H, He K, Tong D, Song T
Oncol Lett. 2017; 13(1):329-338.
PMID: 28123563
PMC: 5245075.
DOI: 10.3892/ol.2016.5423.
MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.
Yang Y, Chang S, Zhao Z, Hou N, He K, Wang X
Oncol Lett. 2016; 10(6):3779-3784.
PMID: 26788207
PMC: 4665883.
DOI: 10.3892/ol.2015.3745.
MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer.
Pal M, Jaiswar S, Dwivedi V, Tripathi A, Dwivedi A, Sankhwar P
Cancer Biol Med. 2016; 12(4):328-41.
PMID: 26779370
PMC: 4706521.
DOI: 10.7497/j.issn.2095-3941.2015.0024.
Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma.
Goudarzi P, Taheriazam A, Asghari S, Jamshidi M, Shakeri M, Yahaghi E
Tumour Biol. 2015; 37(5):5775-9.
PMID: 26385770
DOI: 10.1007/s13277-015-4090-y.
Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
Hiyoshi Y, Schetter A, Okayama H, Inamura K, Anami K, Nguyen G
PLoS One. 2015; 10(4):e0124899.
PMID: 25894979
PMC: 4404052.
DOI: 10.1371/journal.pone.0124899.
Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
Pekow J, Meckel K, Dougherty U, Butun F, Mustafi R, Lim J
Am J Physiol Gastrointest Liver Physiol. 2014; 308(3):G179-87.
PMID: 25477374
PMC: 4312953.
DOI: 10.1152/ajpgi.00208.2014.
Role of microRNAs in gastric cancer.
Ishiguro H, Kimura M, Takeyama H
World J Gastroenterol. 2014; 20(19):5694-9.
PMID: 24914330
PMC: 4024779.
DOI: 10.3748/wjg.v20.i19.5694.